Jan Drappatz, M.D., a leading expert in brain cancer treatment and research, has been appointed associate director of UPMC Cancer Centers Adult Neuro-Oncology Program, and associate professor of neurology and medicine with the University of Pittsburgh School of Medicine.
Dr. Drappatz joined Pitt and UPMC Cancer Centers on Aug. 15 from Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, where he served on the faculty and as an attending physician in the departments of neurology and oncology.
“Jan’s clinical and translational research experience will play a pivotal role in developing a multidisciplinary treatment approach to patients with brain tumors and to those suffering from the neurological effects of their underlying cancer,” said Edward Chu, M.D., chief of the Division of Hematology/Oncology.
Dr. Drappatz received his M.D. from the Johannes Gutenberg University School of Medicine. He completed residency training in neurology at the Partners Neurology Residency Program at Massachusetts General Hospital and Brigham and Women’s Hospital, Harvard Medical School, and completed his fellowship training in neuro-oncology at Dana-Farber.
Follow this hyperlink for a high-resolution photo of Dr. Drappatz.